[Federal Register Volume 88, Number 50 (Wednesday, March 15, 2023)]
[Notices]
[Page 16017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05296]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0007]


Advisory Committee on Immunization Practices; Amended Notice of 
Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) announces 
an amendment to the following meeting of the Advisory Committee on 
Immunization Practices (ACIP). This meeting was open to the public.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, Mailstop H24-8, Atlanta, Georgia 30329-4027; Telephone: 404-
639-8367; Email: [email protected].

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Advisory Committee on Immunization Practices (ACIP); 
February 22, 2023, 8:00 a.m. to 5:15 p.m., EST, February 23, 2023, 8:00 
a.m. to 5:00 p.m., EST, and February 24, 2023, 8:00 a.m. to 1:00 p.m., 
EST (times subject to change, see the ACIP website for updates: http://www.cdc.gov/vaccines/acip/index.html), in the original Federal Register 
notice.
    Notice of the virtual meeting was published in the Federal Register 
on Monday, January 30, 2023, Volume 88, Number 19, pages 5883-5884.
    Notice of the virtual meeting is being amended to update the 
matters to be considered, which should read as follows:
    Matters To Be Considered: The agenda will include discussions on 
mpox vaccines, influenza vaccines, pneumococcal vaccine, varicella 
vaccines, meningococcal vaccines, Polio vaccine, respiratory syncytial 
virus vaccine pediatric/maternal, respiratory syncytial virus vaccine 
adult, dengue vaccines, Chikungunya vaccine, and COVID-19 vaccines. A 
recommendation vote on mpox vaccine is scheduled. For more information 
on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Authority: 5 U.S.C. 1001 et. seq.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-05296 Filed 3-14-23; 8:45 am]
BILLING CODE 4163-18-P